Jean Jacques Bienaime - 03 Jun 2025 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
03 Jun 2025
Net transactions value
+$46,900
Form type
4
Filing time
03 Jun 2025, 21:21:39 UTC
Previous filing
26 Mar 2025
Next filing
06 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BIENAIME JEAN JACQUES Director C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL /s/ Sandra Stoneman, Attorney-in-Fact 03 Jun 2025 0001221590

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $46,900 +5,000 +16% $9.38 36,415 03 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction report was $9.38, and the range of prices were between $9.36 and $9.40, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.